You have 9 free searches left this month | to do more

bocidelpar

Bocidelpar is a drug used to treat Duchenne Muscular Dystrophy (DMD), Healthy Volunteers, Hepatic Impairment, and other conditions. Bocidelpar is being actively studied in 3 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
Astellas Pharma Global Development, Inc.Advanced Pharma CR, LLC
Astellas Pharma IncAkron Children's Hospital
Baylor College of Medicine
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction
  • Bocidelpar
  • Placebo
  • Boston, Massachusetts
    Brigham and Women's Hospital
2022-03-17
Mar 17, 2022
A
Completed
  • Hepatic Impairment
  • Healthy Volunteers
  • Bocidelpar
  • Miami, Florida
  • +2 more
2022-02-04
Feb 4, 2022
A
Recruiting
  • Primary Mitochondrial Myopathy
  • Bocidelpar
  • Placebo
  • Phoenix, Arizona
  • +12 more
2022-03-29
Mar 29, 2022
A
Recruiting
  • Duchenne Muscular Dystrophy (DMD)
  • Bocidelpar
  • Placebo
  • Los Angeles, California
  • +8 more
2022-03-17
Mar 17, 2022